Inventor profile of:

Simon GOODMAN

City:

Griesheim

Country:

Germany

Published Applications:

18

Last publication date:

2016-08-11

Top Assignees for applications by Simon GOODMAN

The entities that hold a legal rights for patent applications filed by inventor GOODMAN Simon:

Recent patent applications by GOODMAN Simon

Simon GOODMAN from Griesheim, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-08-11
US20160228551A1
Human necessities

Method of treating disorders using a pharmaceutical composition of oligopeptides

#2 | 2013-10-31
US20130289259A1
Chemistry; metallurgy

APTAMER LABELLED WITH F-19 NUCLEUS FOR TARGETED MOLECULAR IMAGING BY MRI

#3 | 2013-08-08
US20130203079A1
Chemistry; metallurgy

Antibodies for the detection of integrin complexes in FFPE material

#4 | 2011-09-15
US20110223167A1
Chemistry; metallurgy

COMBINATION THERAPY USING RECEPTOR TYROSINE KINASE INHIBITORS AND ANGIOGENESIS INHIBITORS

#5 | 2011-07-21
US20110177027A1
Human necessities

COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha

#6 | 2011-07-07
US20110165150A1
Human necessities

Isolated organ perfusion combination therapy of cancer

#7 | 2010-10-07
US20100254977A1
Chemistry; metallurgy

Engineered anti-alpha V-integrin hybrid antibodies

#8 | 2010-07-29
US20100190957A1
Human necessities

SPECIFIC THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER

#9 | 2009-12-15
US10471836
-

Inhibitors of integrin αβ

#10 | 2009-05-21
US20090130098A1
Human necessities

Specific therapy using integrin ligands for treating cancer

#11 | 2009-02-05
US20090035270A1
Human necessities

COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha

#12 | 2007-05-24
US20070117849A1
Human necessities

Alfavbeta3 and alfavbet6 integrin antagonists as antifibrotic agents

#13 | 2006-11-14
US10450855
-

Urea and urethane derivatives as integrin inhibitors

#14 | 2006-10-24
US10362028
-

Identification of a human N-terminal acetyltransferase gene

#15 | 2006-06-29
US20060142548A1
Physics

Methods of identifying and designing cell surface receptor inhibitors

#16 | 2006-05-02
US10220858
-

Human extracellular signal regulated kinases

#17 | 2005-07-14
US20050153902A1
Chemistry; metallurgy

Inhibitors of integrin αβ

#18 | 2005-04-28
US20050090525A1
Chemistry; metallurgy

Isoquinoline derivatives

InventorID:

377323 ⎘